David Linetsky - 12 Sep 2023 Form 4 Insider Report for Phreesia, Inc. (PHR)

Signature
Alexis Lyons, as Attorney-in-Fact for David Linetsky
Issuer symbol
PHR
Transactions as of
12 Sep 2023
Net transactions value
+$30,417
Form type
4
Filing time
14 Sep 2023, 17:04:46 UTC
Previous filing
18 Jul 2023
Next filing
20 Sep 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHR Common Stock Award +3,279 +1.6% 207,320 12 Sep 2023 Direct F1
transaction PHR Common Stock Options Exercise $2,237 +475 +0.23% $4.71* 207,795 12 Sep 2023 Direct
transaction PHR Common Stock Options Exercise $45,683 +5,689 +2.7% $8.03 213,484 12 Sep 2023 Direct
transaction PHR Common Stock Options Exercise $26,795 +5,689 +2.7% $4.71* 219,173 12 Sep 2023 Direct
transaction PHR Common Stock Award +273 +3.5% 8,081 12 Sep 2023 By spouse F2
transaction PHR Common Stock Sale $40,139 -1,977 -0.9% $20.30 217,196 13 Sep 2023 Direct F3, F4
transaction PHR Common Stock Sale $1,739 -82 -0.04% $21.20 217,114 13 Sep 2023 Direct F3, F5
transaction PHR Common Stock Sale $2,315 -114 -1.4% $20.30 7,967 13 Sep 2023 By spouse F3, F4
transaction PHR Common Stock Sale $106 -5 -0.06% $21.20 7,962 13 Sep 2023 By spouse F3, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHR Stock Option Options Exercise $0 -5,689 -100% $0.000000* 0 12 Sep 2023 Common Stock 5,689 $8.03 Direct F6
transaction PHR Stock Option Options Exercise $0 -475 -100% $0.000000* 0 12 Sep 2023 Common Stock 475 $4.71 Direct F6
transaction PHR Stock Option Options Exercise $0 -5,689 -100% $0.000000* 0 12 Sep 2023 Common Stock 5,689 $4.71 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the first half of the fiscal year ending January 31, 2024 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his cash bonus into RSUs representing 115% of the earned cash bonus amount. The number of RSUs granted is based on a per share value of $21.27, the closing price of the Issuer's common stock on September 12, 2023.
F2 Represents RSUs that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's spouse's cash bonus earned for the fiscal first half of the year ending January 31, 2024 under the Issuer's Variable Compensation Plan. The Reporting Person's spouse elected to convert such portion of her earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted is based on a per share value of $21.27, the closing price of the Issuer's common stock on September 12, 2023.
F3 These shares were disposed of in non-discretionary transactions pursuant to the Issuer's mandatory sell-to-cover policy to cover the Reporting Person's tax withholding obligations in connection with the settlement of an award of RSUs.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.11 to $21.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.17 to $21.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 This option is fully vested and exercisable as of the date hereof.